Evidence map›Paper›PMID 41124102›Full record

ArticleHealth promotion and chronic disease prevention in Canada : research, policy and practice2025

Prevalence of childhood cancer in Canada: an analysis using 5-year, 18-year and 25-year limited-duration prevalence from the CYP-C data tool.

Katherine McKenzie, Lin Xie, Rana Khafagy, Christina Ricci, Vera Grywacheski

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Health promotion and chronic disease prevention in Canada : research, policy and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katherine McKenzieCentre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Lin XieCentre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Rana KhafagyCentre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Christina RicciCentre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada.
Vera GrywacheskiCentre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Survivors of childhood cancers can face life-long health risks. In this study we describe the prevalence of childhood cancer in Canada by type, geographic region, year, age group and sex, using publicly available data in the Cancer in Young People in Canada (CYP-C) data tool. By 2021, 4325 people aged less than 20 years who had received a cancer diagnosis within the previous 5 years were still alive. The age-standardized 5-year prevalence increased by 12% over the past 15 years. Leukemia was the most prevalent childhood cancer. The CYP-C data tool provides comprehensive and timely public health surveillance statistics to understand the burden of childhood cancer.

Indexed as

Cancer SurvivorsNeoplasmsAdolescentAdultCanadaChildChild, PreschoolFemaleHumansInfantInfant, NewbornMalePrevalenceYoung Adultchildincidencemedical oncologyneoplasmsprevalencepublic health surveillancesurvivors of childhood cancer

Identifiers

PMID41124102
PMCPMC12652272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.